Shaftesbury Capital PLC
Shaftesbury Capital PLC (CCPPF) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for Shaftesbury Capital PLC (CCPPF), covering cash flow, earnings, and balance sheets.
Shaftesbury Capital PLC (CCPPF) Income Statement & Financial Overview
Explore comprehensive income reports for Shaftesbury Capital PLC CCPPF, broken down by year and quarter.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| Revenue | $111.70M | $115.60M | $113.63M | $56.40M |
| Cost of Revenue | $28.20M | $30.50M | $29.21M | $14.55M |
| Gross Profit | $83.50M | $85.10M | $84.42M | $41.85M |
| Gross Profit Ratio | $0.75 | $0.74 | $0.74 | $0.74 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $28.30M | $19.80M | $0.00 | $10.55M |
| Operating Expenses | $28.30M | -$25.50M | $48.86M | $51.95M |
| Total Costs & Expenses | -$56.50M | $5.00M | $78.07M | $66.50M |
| Interest Income | $11.50M | $0.00 | $11.99M | $14.15M |
| Interest Expense | $0.00 | $0.00 | $40.60M | $0.00 |
| Depreciation & Amortization | $400000.00 | $600000.00 | $302218.00 | $150000.00 |
| EBITDA | $55.60M | $121.80M | $35.86M | $31.30M |
| EBITDA Ratio | $0.50 | $1.05 | $0.32 | $0.55 |
| Operating Income | $55.20M | $110.60M | $35.56M | $31.15M |
| Operating Income Ratio | $0.49 | $0.96 | $0.31 | $0.55 |
| Other Income/Expenses (Net) | $110.90M | -$24.30M | -$84.42M | -$55.40M |
| Income Before Tax | $166.10M | $86.30M | -$48.86M | -$24.25M |
| Income Before Tax Ratio | $1.49 | $0.75 | -$0.43 | -$0.43 |
| Income Tax Expense | $100000.00 | $200000.00 | $201478.00 | $100000.00 |
| Net Income | $166.00M | $86.10M | -$49.06M | -$24.35M |
| Net Income Ratio | $1.49 | $0.74 | -$0.43 | -$0.43 |
| EPS | $0.09 | $0.05 | -$0.02 | -$0.01 |
| Diluted EPS | $0.09 | $0.05 | -$0.02 | -$0.01 |
| Weighted Avg Shares Outstanding | $1.95B | $1.83B | $2.48B | $1.82B |
| Weighted Avg Shares Outstanding (Diluted) | $1.95B | $1.83B | $2.48B | $1.82B |
The company's financials show resilient growth, with revenue advancing from $56.40M in Q3 2023 to $111.70M in Q4 2024. Gross profit remained healthy with margins at 75% in Q4 2024 compared to 74% in Q3 2023. Operating income hit $55.20M last quarter, sustaining a consistent 49% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $55.60M. Net income rose to $166.00M, while earnings per share reached $0.09. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan